Preparing for Interoperability of Ultra-Sensitive Disclosures - Webinar Archives
Anasazi Software founder and CEO, Michael Morris, will present a cutting edge concept for providing Meaningful Use Stage 2 interoperability of ultra-sensitive disclosures. While HIEs and RHIOs currently meet HIPAA guidelines for privacy, this new model moves past that and discusses how you can meet the more stringent legal requirements of ultra-sensitive interoperability such as those for the 42 CFR Part 2 federal regulations for substance abuse.
This concept, which has been featured at conferences across the country, allows a provider organization to securely communicate provider to provider, provider to HIE/RHIO, provider to ACO, to a Personal Health Record and within many other exchange permutations.
Since this type of interoperability will be required to meet Stage 2 Meaningful Use, providers need to start planning today for supporting ultra-sensitive disclosures.
Learning Objectives:
- Understanding Stage 2 Meaningful Use Requirements of data exchange
- Learning differences between HIPAA and 42 CFR Part 2 compliance
- Finding out how RHIOs will be moving towards CCD use
- Understanding how to electronically manage consents and disclosures
Michael D. Morris
Chief Executive Officer
Anasazi Software
Mike Morris started his career in the IT world of the healthcare industry in the late 70s and his roots run deep in the non-profit behavioral health field. After working in this sector for a decade and consulting to the medical industry infusing information technology, he began his own company to build a system for a community mental health center in Texas. That initial custom built system launched Anasazi Software to become one of the largest behavioral health software vendors on the market and a company that has proven to be a thought leader since 1989. In the early years, Michael was instrumental in initial product design and development, creation of implementation strategy, support department builds and customer relations. His hands on experience in every aspect of the company has provided him wisdom not seen in most CEOs and provides him the ability to see far into the future of the healthcare industry. Michael is often a featured speaker and panelist at conferences, leads organizations like the Software and Technology Vendor's Alliance and continues to drive innovation in the behavioral health technology field.
